(WKBN) – Every year, thousands of people die from overdosing on opioids in the U.S. but now there’s a new, non-opioid pain medication that’s just been approved by the FDA. Suzetrigine is the first ...

A new drug is providing hope for patients with severe or moderate acute pain, offering an alternative that is designed to be less harmful than opioids. The drug, called Journavx, is part of a broader ...

Please provide your email address to receive an email when new articles are posted on . Sensitivities to acetaminophen and NSAIDs are common but vary. Topical pain relief solutions may provide fewer ...

Joint pain can be caused by a number of biological, psychological, and social factors. The most common cause of joint pain is different types of arthritis. There is a wide availability of medications ...

A new opioid-free pain medication was approved by the U.S. Food and Drug Administration (FDA) on Thursday, marking a non-addictive alternative for patients. Journavx (suzetrigine), made by Vertex, is ...

This new nonaddictive alternative is the first of its kind that interrupts the pain signal before it reaches the brain. A new kind of pain medication has been approved for sale by the Food and Drug ...

An estimated one in five Americans live with chronic pain and current treatment options leave much to be desired. Scientists are now using artificial intelligence (AI) for drug discovery in advanced ...

The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than two decades. The drug, suzetrigine, is a 50-milligram prescription pill ...

A New Orleans-based biotech company has developed a breakthrough non-opioid pain medication, which is backed by funding from Ochsner Ventures, the investment arm of Ochsner Health, and from Gulf South ...